JP2009541274A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009541274A5 JP2009541274A5 JP2009515894A JP2009515894A JP2009541274A5 JP 2009541274 A5 JP2009541274 A5 JP 2009541274A5 JP 2009515894 A JP2009515894 A JP 2009515894A JP 2009515894 A JP2009515894 A JP 2009515894A JP 2009541274 A5 JP2009541274 A5 JP 2009541274A5
- Authority
- JP
- Japan
- Prior art keywords
- nkg2
- soluble
- receptor
- seq
- nkg2a
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06115901 | 2006-06-22 | ||
| EP06115901.8 | 2006-06-22 | ||
| PCT/EP2007/056276 WO2007147898A1 (en) | 2006-06-22 | 2007-06-22 | Soluble heterodimeric receptors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009541274A JP2009541274A (ja) | 2009-11-26 |
| JP2009541274A5 true JP2009541274A5 (https=) | 2013-01-31 |
| JP5368301B2 JP5368301B2 (ja) | 2013-12-18 |
Family
ID=36764002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009515894A Expired - Fee Related JP5368301B2 (ja) | 2006-06-22 | 2007-06-22 | 可溶性ヘテロ二量体レセプター及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7932055B2 (https=) |
| EP (1) | EP2035452B1 (https=) |
| JP (1) | JP5368301B2 (https=) |
| AT (1) | ATE555383T1 (https=) |
| ES (1) | ES2385754T3 (https=) |
| WO (1) | WO2007147898A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10865233B2 (en) | 2008-12-18 | 2020-12-15 | Dana-Farber Cancer Institute, Inc. | NKG2D-fc for immunotherapy |
| DK3143134T3 (da) | 2014-05-15 | 2021-01-04 | Nat Univ Singapore | Modificerede, naturlige dræberceller og anvendelser deraf |
| US10329348B2 (en) | 2014-10-23 | 2019-06-25 | Innate Pharma | Treatment of cancers using anti-NKG2A agents |
| EP3373970A4 (en) | 2015-11-13 | 2019-07-10 | Dana Farber Cancer Institute, Inc. | NKG2D IG FUSION PROTEIN FOR CANCER IMMUNOTHERAPY |
| WO2017156461A2 (en) * | 2016-03-10 | 2017-09-14 | Aperisys, Inc. | Antigen-binding fusion proteins with modified hsp70 domains |
| CA3056591A1 (en) | 2017-03-27 | 2018-10-04 | National University Of Singapore | Stimulatory cell lines for ex vivo expansion and activation of natural killer cells |
| BR112019019917A2 (pt) | 2017-03-27 | 2020-04-22 | Nat Univ Singapore | receptores quiméricos nkg2d truncados e seus usos em imunoterapia de células exterminadoras naturais |
| CN108101975B (zh) * | 2017-12-14 | 2020-05-15 | 中国科学院昆明动物研究所 | 一种森林山蛭抗血栓多肽Sylvestin及其体外表达制备方法和应用 |
| EP3749685A4 (en) * | 2018-02-09 | 2021-12-22 | National University of Singapore | ACTIVATOR CHEMERIC RECEPTORS AND THEIR USES IN NATURAL KILLING CELL IMMUNOTHERAPY |
| WO2019175182A1 (en) | 2018-03-13 | 2019-09-19 | Innate Pharma | Treatment of head and neck cancer |
| JP7334985B2 (ja) | 2018-04-02 | 2023-08-29 | ナショナル ユニヴァーシティー オブ シンガポール | 免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和 |
| EP3844186A4 (en) | 2018-08-29 | 2022-08-17 | National University of Singapore | METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS |
| CA3120563A1 (en) | 2018-11-26 | 2020-06-04 | Nkarta, Inc. | Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy |
| MX2021006194A (es) * | 2018-12-02 | 2021-06-30 | Fate Therapeutics Inc | Inmunoterapias mediante el uso de celulas efectoras potenciadas derivadas de ipsc. |
| EP3773918A4 (en) | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY |
| JP2022532430A (ja) * | 2019-05-16 | 2022-07-14 | シャタック ラボ，インコーポレイテッド | Ｎｋ細胞指向性キメラタンパク質 |
| GB201909509D0 (en) * | 2019-07-02 | 2019-08-14 | Immunocore Ltd | Peptide-MHC complexes |
| EP3999850A1 (en) * | 2019-07-16 | 2022-05-25 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) | Nmda receptor constructs to detect and isolate nmdar autoantibodies |
| CN111303296B (zh) * | 2019-12-16 | 2021-01-29 | 启辰生生物科技(珠海)有限公司 | 双功能融合多肽、细胞和药物组合物及应用 |
| CN111122848A (zh) * | 2019-12-30 | 2020-05-08 | 浙江工业大学 | 一种用于筛选hgfr靶向抗体的elisa试剂盒及应用 |
| EP4615978A1 (en) * | 2022-11-07 | 2025-09-17 | Senti Biosciences, Inc. | Methods and compositions for cell-surface co-localization of chimeric proteins |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6018026A (en) | 1988-01-22 | 2000-01-25 | Zymogenetics, Inc. | Biologically active dimerized and multimerized polypeptide fusions |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| JPH06506358A (ja) | 1991-03-28 | 1994-07-21 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミネソタ | ナチュラルキラー細胞に特異的なｄｎａおよびアミノ酸配列 |
| US6238890B1 (en) | 1994-02-18 | 2001-05-29 | Washington University | Single chain forms of the glycoprotein hormone quartet |
| US5783672A (en) | 1994-05-26 | 1998-07-21 | Immunex Corporation | Receptor for oncostatin M |
| ITFI940106A1 (it) | 1994-05-27 | 1995-11-27 | Menarini Ricerche Sud Spa | Molecola ibrida di formula gm-csf-l-epo o epo-l-gm-csf per la stimolaz ione eritropoietica |
| US6066322A (en) * | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| CA2258721C (en) | 1996-07-12 | 2014-09-09 | Genentech, Inc. | Chimeric heteromultimer adhesins |
| ATE299938T1 (de) | 1997-05-02 | 2005-08-15 | Genentech Inc | Ein verfahren zur herstellung multispezifischer antikörper die heteromultimere und gemeinsame komponenten besitzen |
| US20020062010A1 (en) * | 1997-05-02 | 2002-05-23 | Genentech, Inc. | Method for making multispecific antibodies having heteromultimeric and common components |
| US6982142B2 (en) | 1997-12-01 | 2006-01-03 | John Wayne Cancer Institute | Methods for screening therapeutically effective agents |
| GB9725764D0 (en) * | 1997-12-04 | 1998-02-04 | Isis Innovation | HLA-E binding |
| ES2590912T3 (es) | 1997-12-08 | 2016-11-24 | Merck Patent Gmbh | Proteínas de fusión heterodiméricas útiles para inmunoterapia dirigida y estimulación general del sistema inmunitario |
| EP1047781B1 (en) | 1998-01-23 | 2004-07-28 | Immunex Corporation | Il-18 receptors |
| EP1001030A1 (en) * | 1998-09-22 | 2000-05-17 | Boehringer Ingelheim International GmbH | Recombinant CELO virus and CELO virus DNA |
| HUP0204475A2 (en) * | 2000-02-11 | 2003-04-28 | Merck Patent Gmbh | Enhancing the circulating half-life of antibody-based fusion proteins |
| US6853997B2 (en) | 2000-06-29 | 2005-02-08 | Infoglide Corporation | System and method for sharing, mapping, transforming data between relational and hierarchical databases |
| IL137419A0 (en) | 2000-07-20 | 2001-07-24 | Yissum Res Dev Co | Nk cells activating receptors and their therapeutic and diagnostic uses |
| US20020052475A1 (en) * | 2000-07-20 | 2002-05-02 | Schering Ag | High affinity soluble interleukin-18 receptor |
| DE60123998T2 (de) | 2000-08-08 | 2007-09-06 | Zymogenetics, Inc., Seattle | Lösliche zcyctor 11 cytokinrezeptoren |
| ATE333888T1 (de) | 2000-09-15 | 2006-08-15 | Zymogenetics Inc | Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen |
| CN1533438A (zh) | 2001-06-08 | 2004-09-29 | �����Ŵ��Ƽ���˾ | 在植物生产蛋白质的方法 |
| KR100453877B1 (ko) * | 2001-07-26 | 2004-10-20 | 메덱스젠 주식회사 | 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체 |
| US6833441B2 (en) | 2001-08-01 | 2004-12-21 | Abmaxis, Inc. | Compositions and methods for generating chimeric heteromultimers |
-
2007
- 2007-06-22 EP EP07786810A patent/EP2035452B1/en not_active Not-in-force
- 2007-06-22 ES ES07786810T patent/ES2385754T3/es active Active
- 2007-06-22 JP JP2009515894A patent/JP5368301B2/ja not_active Expired - Fee Related
- 2007-06-22 AT AT07786810T patent/ATE555383T1/de active
- 2007-06-22 US US12/305,678 patent/US7932055B2/en not_active Expired - Fee Related
- 2007-06-22 WO PCT/EP2007/056276 patent/WO2007147898A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009541274A5 (https=) | ||
| JP7457764B2 (ja) | ヘテロ二量体多重特異性抗体フォーマット | |
| US12187763B2 (en) | Chromatography resin and uses thereof | |
| JP6454363B2 (ja) | 単一ドメイン抗原結合分子の精製方法 | |
| JP2020186248A5 (https=) | ||
| AU2018390418A1 (en) | Engineered IL-2 FC fusion proteins | |
| Nilsson et al. | Multiple affinity domains for the detection, purification and immobilization of recombinant proteins | |
| CN103459427B (zh) | 针对人IgG抗体的CH1结构域中表位的抗原结合蛋白 | |
| CN111491951A (zh) | 通过疏水相互作用色谱法耗尽轻链错配的抗体变体 | |
| CN105229036A (zh) | 在疏水性相互作用位点内引入了静电相互作用的蛋白及其制备方法 | |
| WO2021168194A1 (en) | Engineered anti-her2 bispecific proteins | |
| CN104540853A (zh) | 含有包含蛋白g的细胞膜外结构域变体的串联型多聚体的蛋白质的捕获剂 | |
| JP2023533529A (ja) | アフィニティ精製のための免疫グロブリン結合タンパク質 | |
| CN106188251A (zh) | 一种免疫球蛋白结合蛋白突变体及其用途 | |
| EP4255934A1 (en) | Heterodimeric iga fc constructs and methods of use thereof | |
| WO2022125986A1 (en) | Orthogonal mutations for heterodimerization | |
| JP2000247999A (ja) | 固定化蛋白質の製造法 | |
| EP4545554A1 (en) | A recombinant polypeptide comprising a metal-binding motif | |
| CN122003432A (zh) | 包括金属结合基序的重组多肽 | |
| Sohma et al. | Recognition of size and charged states of antigens by anti-peptide antibodies | |
| CN118119402A (zh) | 工程化抗her2双特异性蛋白 | |
| RU2021120860A (ru) | Мультиспецифические связывающие белки на основе псевдо-fab |